Indian J Pharm Close
 

Figure 1: (a) Day-1 urine cytology smear showing predominantly lymphoid cells (Giemsa, ×100); (b) Urothelial cells along with lymphoid cells and occasional eosinophil on day 2 urine sample (Pap, ×100); (c and d) These structures on day 2 sample (Giemsa, [c] ×200 and [d] ×400]; (e and f) Day 4 urine cytology showing the structures with urothelial cells and lymphocytes (Pap, [e]×100 and [f]×400).

Figure 1: (a) Day-1 urine cytology smear showing predominantly lymphoid cells (Giemsa, ×100); (b) Urothelial cells along with lymphoid cells and occasional eosinophil on day 2 urine sample (Pap, ×100); (c and d) These structures on day 2 sample (Giemsa, [c] ×200 and [d] ×400]; (e and f) Day 4 urine cytology showing the structures with urothelial cells and lymphocytes (Pap, [e]×100 and [f]×400).